You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 21, June 6, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •JAMA News Video
 •Author in the Room Teleconference
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (117)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Randomized Controlled Trial
 •Drug Therapy, Other
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Folic Acid for the Prevention of Colorectal Adenomas

A Randomized Clinical Trial

Bernard F. Cole, PhD; John A. Baron, MD; Robert S. Sandler, MD; Robert W. Haile, DrPh; Dennis J. Ahnen, MD; Robert S. Bresalier, MD; Gail McKeown-Eyssen, PhD; Robert W. Summers, MD; Richard I. Rothstein, MD; Carol A. Burke, MD; Dale C. Snover, MD; Timothy R. Church, PhD; John I. Allen, MD; Douglas J. Robertson, MD; Gerald J. Beck, PhD; John H. Bond, MD; Tim Byers, MD, MPH; Jack S. Mandel, PhD, MPH; Leila A. Mott, MS; Loretta H. Pearson, MPhil; Elizabeth L. Barry, PhD; Judy R. Rees, BM, BCh, MPH, PhD; Norman Marcon, MD; Fred Saibil, MD; Per Magne Ueland, MD; E. Robert Greenberg, MD; for the Polyp Prevention Study Group

JAMA. 2007;297:2351-2359.

Context  Laboratory and epidemiological data suggest that folic acid may have an antineoplastic effect in the large intestine.

Objective  To assess the safety and efficacy of folic acid supplementation for preventing colorectal adenomas.

Design, Setting, and Participants  A double-blind, placebo-controlled, 2-factor, phase 3, randomized clinical trial conducted at 9 clinical centers between July 6, 1994, and October 1, 2004. Participants included 1021 men and women with a recent history of colorectal adenomas and no previous invasive large intestine carcinoma.

Intervention  Participants were randomly assigned in a 1:1 ratio to receive 1 mg/d of folic acid (n = 516) or placebo (n = 505), and were separately randomized to receive aspirin (81 or 325 mg/d) or placebo. Follow-up consisted of 2 colonoscopic surveillance cycles (the first interval was at 3 years and the second at 3 or 5 years later).

Main Outcome Measures  The primary outcome measure was occurrence of at least 1 colorectal adenoma. Secondary outcomes were the occurrence of advanced lesions (≥25% villous features, high-grade dysplasia, size ≥1 cm, or invasive cancer) and adenoma multiplicity (0, 1-2, or ≥3 adenomas).

Results  During the first 3 years, 987 participants (96.7%) underwent colonoscopic follow-up, and the incidence of at least 1 colorectal adenoma was 44.1% for folic acid (n = 221) and 42.4% for placebo (n = 206) (unadjusted risk ratio [RR], 1.04; 95% confidence interval [CI], 0.90-1.20; P = .58). Incidence of at least 1 advanced lesion was 11.4% for folic acid (n = 57) and 8.6% for placebo (n = 42) (unadjusted RR, 1.32; 95% CI, 0.90-1.92; P = .15). A total of 607 participants (59.5%) underwent a second follow-up, and the incidence of at least 1 colorectal adenoma was 41.9% for folic acid (n = 127) and 37.2% for placebo (n = 113) (unadjusted RR, 1.13; 95% CI, 0.93-1.37; P = .23); and incidence of at least 1 advanced lesion was 11.6% for folic acid (n = 35) and 6.9% for placebo (n = 21) (unadjusted RR, 1.67; 95% CI, 1.00-2.80; P = .05). Folic acid was associated with higher risks of having 3 or more adenomas and of noncolorectal cancers. There was no significant effect modification by sex, age, smoking, alcohol use, body mass index, baseline plasma folate, or aspirin allocation.

Conclusions  Folic acid at 1 mg/d does not reduce colorectal adenoma risk. Further research is needed to investigate the possibility that folic acid supplementation might increase the risk of colorectal neoplasia.

Trial Registration  clinicaltrials.gov Identifier: NCT00272324


Author Affiliations: Departments of Community and Family Medicine (Drs Cole, Baron, Barry, Rees, and Greenberg, and Mss Mott and Pearson) and Medicine (Drs Baron, Rothstein, and Greenberg), Dartmouth Medical School, Hanover, NH; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill (Dr Sandler); Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles (Dr Haile); Departments of Medicine (Dr Ahnen) and Preventive Medicine and Biometrics (Dr Byers), University of Colorado, Denver; Department of Gastrointestinal Medicine and Nutrition, MD Anderson Cancer Center, Houston, Tex (Dr Bresalier); Departments of Public Health Sciences and Nutritional Sciences (Dr McKeown-Eyssen) and Medicine (Drs Marcon and Saibil), University of Toronto, Toronto, Ontario; Division of Gastroenterology/Hepatology, University of Iowa Carver College of Medicine, Iowa City (Dr Summers); Departments of Gastroenterology (Dr Burke) and Quantitative Health Sciences (Dr Beck), The Cleveland Clinic Foundation, Cleveland, Ohio; Department of Pathology, Fairview Southdale Hospital, Edina, Minn (Dr Snover); Division of Environmental Health Sciences, University of Minnesota School of Public Health, Minneapolis (Dr Church); Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minn (Dr Bond); Minnesota Gastroenterology PA, Plymouth (Dr Allen); Section of Gastroenterology, Department of Veterans Affairs Medical Center, White River Junction, Vt (Dr Robertson); Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Ga (Dr Mandel); and Section of Pharmacology, Institute of Medicine, University of Bergen and Haukeland University Hospital, Bergen, Norway (Dr Ueland).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Folate is absorbed across the colon of adults: evidence from cecal infusion of 13C-labeled [6S]-5-formyltetrahydrofolic acid
Aufreiter et al.
Am. J. Clin. Nutr. 2009;90:116-123.
ABSTRACT | FULL TEXT  

Polymorphisms in uracil-processing genes, but not one-carbon nutrients, are associated with altered DNA uracil concentrations in an urban Puerto Rican population
Chanson et al.
Am. J. Clin. Nutr. 2009;89:1927-1936.
ABSTRACT | FULL TEXT  

Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apcmin/+ mice
Lawrance et al.
Gut 2009;58:805-811.
ABSTRACT | FULL TEXT  

Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They Fail
Bode and Dong
Cancer Prevention Research 2009;2:514-517.
FULL TEXT  

Serum Folate and Cancer Mortality Among U.S. Adults: Findings from the Third National Health and Nutritional Examination Survey Linked Mortality File
Yang et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1439-1447.
ABSTRACT | FULL TEXT  

Micronutrients and Older Adults
Marian and Sacks
Nutr Clin Pract 2009;24:179-195.
ABSTRACT | FULL TEXT  

Global DNA Hypomethylation (LINE-1) in the Normal Colon and Lifestyle Characteristics and Dietary and Genetic Factors
Figueiredo et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1041-1049.
ABSTRACT | FULL TEXT  

Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical Trial
Figueiredo et al.
JNCI J Natl Cancer Inst 2009;101:432-435.
ABSTRACT | FULL TEXT  

Nutritional Prevention of Cancer: New Directions for an Increasingly Complex Challenge
Kristal and Lippman
JNCI J Natl Cancer Inst 2009;101:363-365.
FULL TEXT  

Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age
Nguyen et al.
Am. J. Clin. Nutr. 2009;89:844-852.
ABSTRACT | FULL TEXT  

Maternal Vitamin B12 Status and Risk of Neural Tube Defects in a Population With High Neural Tube Defect Prevalence and No Folic Acid Fortification
Molloy et al.
Pediatrics 2009;123:917-923.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drug Use After 3 Years of Aspirin Use and Colorectal Adenoma Risk: Observational Follow-up of a Randomized Study
Grau et al.
JNCI J Natl Cancer Inst 2009;101:267-276.
ABSTRACT | FULL TEXT  

Multivitamin Use and Risk of Cancer and Cardiovascular Disease in the Women's Health Initiative Cohorts
Neuhouser et al.
Arch Intern Med 2009;169:294-304.
ABSTRACT | FULL TEXT  

Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk
Maruti et al.
Am. J. Clin. Nutr. 2009;89:624-633.
ABSTRACT | FULL TEXT  

Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease
Heyman et al.
Am. J. Clin. Nutr. 2009;89:545-550.
ABSTRACT | FULL TEXT  

Is it time for vitamin B-12 fortification? What are the questions?
Green
Am. J. Clin. Nutr. 2009;89:712S-716S.
ABSTRACT | FULL TEXT  

Folate, Related B Vitamins, and Homocysteine in Childhood and Adolescence: Potential Implications for Disease Risk in Later Life
Kerr et al.
Pediatrics 2009;123:627-635.
ABSTRACT | FULL TEXT  

Fruit and Vegetable Intakes Are Associated with Lower Risk of Colorectal Adenomas
Wu et al.
J. Nutr. 2009;139:340-344.
ABSTRACT | FULL TEXT  

Vitamin Supplements and Cancer Prevention: Where Do Randomized Controlled Trials Stand?
Albanes
JNCI J Natl Cancer Inst 2009;101:2-4.
FULL TEXT  

Predicted contribution of folic acid fortification of corn masa flour to the usual folic acid intake for the US population: National Health and Nutrition Examination Survey 2001-2004
Hamner et al.
Am. J. Clin. Nutr. 2009;89:305-315.
ABSTRACT | FULL TEXT  

Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer
Newmark et al.
Carcinogenesis 2009;30:88-92.
ABSTRACT | FULL TEXT  

Folic Acid: Preventive Nutrition for Preconception, the Fetus, and the Newborn
Johnston
NeoReviews 2009;10:e10-e19.
ABSTRACT | FULL TEXT  

Invited Commentary: Preventing Neural Tube Defects and More via Food Fortification?
Mills and Carter
Am J Epidemiol 2009;169:18-21.
ABSTRACT | FULL TEXT  

Contributions of Total Daily Intake of Folic Acid to Serum Folate Concentrations
Yeung et al.
JAMA 2008;300:2486-2487.
FULL TEXT  

Assessing Toxicity in Cancer Chemoprevention Trials: The Other Side of the Coin
Goodman
Cancer Prevention Research 2008;1:499-502.
FULL TEXT  

Dietary Folate, Methionine, Riboflavin, and Vitamin B-6 and Risk of Sporadic Colorectal Cancer
de Vogel et al.
J. Nutr. 2008;138:2372-2378.
ABSTRACT | FULL TEXT  

Perspectives on obesity and sweeteners, folic acid fortification and vitamin D requirements
Halsted
Fam Pract 2008;25:i44-i49.
ABSTRACT | FULL TEXT  

Effect of Combined Folic Acid, Vitamin B6, and Vitamin B12 on Cancer Risk in Women: A Randomized Trial
Zhang et al.
JAMA 2008;300:2012-2021.
ABSTRACT | FULL TEXT  

One-Carbon Metabolism Biomarkers and Risk of Colon and Rectal Cancers
Weinstein et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:3233-3240.
ABSTRACT | FULL TEXT  

Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations
DeVos et al.
Am. J. Clin. Nutr. 2008;88:1149-1158.
ABSTRACT | FULL TEXT  

Colorectal Adenomas in a Randomized Folate Trial: The Role of Baseline Dietary and Circulating Folate Levels
Figueiredo et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2625-2631.
ABSTRACT | FULL TEXT  

Alcohol Drinking and One-Carbon Metabolism-Related Gene Polymorphisms on Pancreatic Cancer Risk
Suzuki et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2742-2747.
ABSTRACT | FULL TEXT  

The promise and challenges of population strategies of prevention
Michels
Int J Epidemiol 2008;37:914-916.
FULL TEXT  

Folic Acid Supplementation and Cancer Risk: Point
Kim
Cancer Epidemiol. Biomarkers Prev. 2008;17:2220-2225.
FULL TEXT  

Folate and Cancer Prevention--Where to Next? Counterpoint
Ulrich
Cancer Epidemiol. Biomarkers Prev. 2008;17:2226-2230.
FULL TEXT  

MTHFR Genotype and Colorectal Adenoma Recurrence: Data from a Double-blind Placebo-controlled Clinical Trial
Levine et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2409-2415.
ABSTRACT | FULL TEXT  

Methylene Tetrahydrofolate Reductase Genotype Modifies the Chemopreventive Effect of Folate in Colorectal Adenoma, but not Colorectal Cancer
Lightfoot et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2421-2430.
ABSTRACT | FULL TEXT  

Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer
de Vogel et al.
Carcinogenesis 2008;29:1765-1773.
ABSTRACT | FULL TEXT  

Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography: A Randomized Controlled Trial
Ebbing et al.
JAMA 2008;300:795-804.
ABSTRACT | FULL TEXT  

Are we ready for mandatory fortification with vitamin B-12?
Refsum and Smith
Am. J. Clin. Nutr. 2008;88:253-254.
FULL TEXT  

Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial
Hao et al.
Am. J. Clin. Nutr. 2008;88:448-457.
ABSTRACT | FULL TEXT  

B-Vitamin Intake, One-Carbon Metabolism, and Survival in a Population-Based Study of Women with Breast Cancer
Xu et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2109-2116.
ABSTRACT | FULL TEXT  

Vitamins B2, B6, and B12 and Risk of New Colorectal Adenomas in a Randomized Trial of Aspirin Use and Folic Acid Supplementation
Figueiredo et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2136-2145.
ABSTRACT | FULL TEXT  

Review: Chemoprevention of esophageal adenocarcinoma
Abrams
Therapeutic Advances in Gastroenterology 2008;1:7-18.
ABSTRACT  

Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank
Yang et al.
Am. J. Clin. Nutr. 2008;88:232-246.
ABSTRACT | FULL TEXT  

Prediagnostic Plasma Folate and the Risk of Death in Patients With Colorectal Cancer
Wolpin et al.
JCO 2008;26:3222-3228.
ABSTRACT | FULL TEXT  

Shedding Light on Colorectal Cancer Prognosis: Vitamin D and Beyond
Ulrich and Holmes
JCO 2008;26:2937-2939.
FULL TEXT  

Does Folic Acid Supplementation Prevent or Promote Colorectal Cancer? Results from Model-Based Predictions
Luebeck et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1360-1367.
ABSTRACT | FULL TEXT  

Multivitamin-multimineral supplement use and mammographic breast density
Berube et al.
Am. J. Clin. Nutr. 2008;87:1400-1404.
ABSTRACT | FULL TEXT  

Is folic acid good for everyone?
Smith et al.
Am. J. Clin. Nutr. 2008;87:517-533.
ABSTRACT | FULL TEXT  

Long-Term Use of Supplemental Multivitamins, Vitamin C, Vitamin E, and Folate Does Not Reduce the Risk of Lung Cancer
Slatore et al.
Am. J. Respir. Crit. Care Med. 2008;177:524-530.
ABSTRACT | FULL TEXT  

Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review
Velicer and Ulrich
JCO 2008;26:665-673.
ABSTRACT | FULL TEXT  

Circulating Concentrations of Folate and Vitamin B12 in Relation to Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study
Johansson et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:279-285.
ABSTRACT | FULL TEXT  

Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults
Hoey et al.
Am. J. Clin. Nutr. 2007;86:1405-1413.
ABSTRACT | FULL TEXT  

The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma
Chu et al.
Ann. Surg. Oncol. 2007;14:3054-3069.
ABSTRACT | FULL TEXT  

Responses of Biomarkers of Folate and Riboflavin Status to Folate and Riboflavin Supplementation in Healthy and Colorectal Polyp Patients (The FAB2 Study)
Powers et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2128-2135.
ABSTRACT | FULL TEXT  

Folic Acid and Prevention of Colorectal Adenomas
Chae and Yun
JAMA 2007;298:1397-1397.
FULL TEXT  

Folic Acid and Vitamin B-12 Supplementation Does Not Favorably Influence Uracil Incorporation and Promoter Methylation in Rectal Mucosa DNA of Subjects with Previous Colorectal Adenomas
van den Donk et al.
J. Nutr. 2007;137:2114-2120.
ABSTRACT | FULL TEXT  

One-Carbon Metabolism, Colorectal Carcinogenesis, Chemoprevention with Caution
Ziegler and Lim
JNCI J Natl Cancer Inst 2007;99:1214-1215.
FULL TEXT  

Folate and cancer prevention: a closer look at a complex picture
Ulrich
Am. J. Clin. Nutr. 2007;86:271-273.
FULL TEXT  

Folic Acid to Prevent Recurrence of Colorectal Adenomas?
JWatch Gastroenterology 2007;2007:4-4.
FULL TEXT  

Good News and Bad News About Colonic Polyps and Prevention of Colon Cancer: The Bad News
JWatch Oncology and Hematology 2007;2007:2-2.
FULL TEXT  

A Temporal Association between Folic Acid Fortification and an Increase in Colorectal Cancer Rates May Be Illuminating Important Biological Principles: A Hypothesis
Mason et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1325-1329.
ABSTRACT | FULL TEXT  

Should folic acid fortification be mandatory? Yes
Wald and Oakley
BMJ 2007;334:1252-1252.
FULL TEXT  

Folate and Cancer--Timing Is Everything
Ulrich and Potter
JAMA 2007;297:2408-2409.
FULL TEXT  

Folic Acid and the Risk for Recurrent Colorectal Adenomas
JWatch General 2007;2007:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.